Internal Medicine, Infectious Disease · Omaha, NE
NPI
1235183369
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7710 Mercy Rd Ste 3000
Omaha, NE, 68124
Phone (402) 717-0759
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
683 services
Medicare patients, 2024
284
Average age 73
Drug cost, 2024
$196K
359 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Quimby was code 99232 (hospital e&m - subsequent), 319 times for 161 patients. In total David S Quimby billed 683 services in 12 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 319 | 161 | $57.00 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 99 | 67 | $85.85 | $8,500 |
| 99223 Hospital E&M - Initial | Facility | 75 | 73 | $124.29 | $9,321 |
| 99222 Hospital E&M - Initial | Facility | 72 | 69 | $93.88 | $6,759 |
| 99214 Office E&M - Established | Office | 49 | 32 | $93.40 | $4,577 |
| 99291 Critical Care E&M | Facility | 32 | 22 | $153.60 | $4,915 |
| 99215 Office E&M - Established | Office | 20 | 16 | $132.14 | $2,643 |
By year: 2022 $40K for 536 services; 2023 $48K for 619 services; 2024 $56K for 683 services.
Medicare prescription drug claims, 2024
In 2024, the drug David S Quimby prescribed most often to Medicare patients was Cephalexin, with 36 prescriptions and refills. In total David S Quimby wrote 359 Medicare prescriptions that cost $196K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 36 | 42 | 14 | $1,538 |
| Cefadroxil Generic | 35 | 68 | 17 | $6,163 |
| Doxycycline Hyclate Generic | 32 | 50 | 17 | $833 |
| Ciprofloxacin Hcl Generic | 22 | 30 | Under 11 | $899 |
| Rifampin Generic | 21 | 25 | Under 11 | $982 |
| Amoxicillin Generic | 16 | 24 | Under 11 | $363 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 15 | 15 | Under 11 | $59K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 15 | 17 | 11 | $459 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 14 | 14 | Under 11 | $443 |
| Minocycline Hcl Generic | 13 | 21 | Under 11 | $791 |
| Levofloxacin Generic | 13 | 16 | Under 11 | $204 |
| Amikacin Sulfate Generic | 12 | 12 | Under 11 | $551 |
| Zidovudine Generic | 12 | 12 | Under 11 | $328 |
Brand drugs: 29 claims; generic drugs: 330 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David S Quimby were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.